Sign In
Buy FATE
$2.45
-0.0600 (-2.39%)
At Close: Jul 31, 2026
Need To Know: Analysts Are Much More Bullish On Fate Therapeutics, Inc. (NASDAQ:FATE) Revenues
12:59pm, Saturday, 04'th Apr 2020
Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders will have a reason to smile today, with the analysts making...
Coronavirus Roundtable - Strains And Hopes In The Healthcare Sector
11:30am, Saturday, 04'th Apr 2020
The healthcare sector is on the front lines of treating, preventing, and ultimately solving the coronavirus issues. We discuss with our panelists how the sector
Raymond James & Associates Trims Position in Fate Therapeutics Inc (NASDAQ:FATE)
09:26am, Saturday, 04'th Apr 2020
Raymond James & Associates lessened its stake in shares of Fate Therapeutics Inc (NASDAQ:FATE) by 15.3% during the 4th quarter, according to the company in its most recent filing with the Securities &
7 Promising Biotech Stocks in a Postpandemic World
10:34pm, Friday, 03'rd Apr 2020
The life-sciences sector will emerge as a winner from the current crisis, says Eli Casdin, founder of Casdin Capital. Why Chinese biotechs look appealing
Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies
10:07pm, Friday, 03'rd Apr 2020
Fate Therapeutics has signed an agreement with Janssen Biotech to develop new cancer cell therapies that are derived from stem cells and landed $100
Mid-Afternoon Market Update: Dow Falls 500 Points; electroCore Shares Spike Higher
06:24pm, Friday, 03'rd Apr 2020
Toward the end of trading Friday, the Dow traded down 2.34% to 20913.26 while the NASDAQ fell 2.48% to 7301.42. The S&P also fell, dropping 2.53% to 2,462.91.
The U.S. is now...
Fate Therapeutics Snags $3 Billion-Plus Deal With Johnson & Johnson
06:17pm, Friday, 03'rd Apr 2020
The companies will be collaborating on immuno-oncology treatments.
Fly Intel: Wall Street's top stories at midday MMM;TSLA;JPM;BAC;C;GS;MS;USB;WFC;BBBY;FATE;JNJ;INCY;MIC;AEHR;CHWY
04:51pm, Friday, 03'rd Apr 2020
Fly Intel: Wall Street's top stories at midday MMM TSLA JPM BAC C GS MS USB WFC BBBY FATE JNJ INCY MIC AEHR CHWY
Here's Why Fate Therapeutics Rose as Much as 18.7% Today
03:59pm, Friday, 03'rd Apr 2020
The cellular therapy developer announced an equity investment from and a partnership with Janssen, a subsidiary of Johnson & Johnson.
Fate Therapeutics Surges on Immunotherapy Deal With J&J
02:57pm, Friday, 03'rd Apr 2020
Fate Therapeutics (FATE) signs agreement with J&J; subsidiary to develop CAR NK and CAR T-cell product candidates for cancer. The deal is likely tocreate significant future revenue stream for the comp
Fate Therapeutics Surges on Immunotherapy Deal With J&J
02:57pm, Friday, 03'rd Apr 2020
Fate Therapeutics (FATE) signs agreement with J&J subsidiary to develop CAR NK and CAR T-cell product candidates for cancer. The deal is likely tocreate significant future revenue stream for the compa
Wedbush Maintains Outperform on Fate Therapeutics, Raises Price Target to $41
02:33pm, Friday, 03'rd Apr 2020TSLA, ET among premarket gainers
01:21pm, Friday, 03'rd Apr 2020
Capricor Therapeutics (NASDAQ:CAPR) +26% on providing its CAP-1002 cell therapy under compassionate use for patients with advanced COVID-19.Fate Therapeutics (NASDAQ:FATE) +19% on J&J cell therapy
Fly Intel: Pre-market Movers JNJ;TSLA;TWTR;FATE;STZ;STZ.B;PLAY;CHWY;MMM;IMMU;NNI
01:14pm, Friday, 03'rd Apr 2020
Fly Intel: Pre-market Movers JNJ TSLA TWTR FATE STZ STZ.B PLAY CHWY MMM IMMU NNI
17 Healthcare Stocks Moving In Friday's Pre-Market Session
11:38am, Friday, 03'rd Apr 2020
Gainers
• electroCore, Inc. (NASDAQ:ECOR) shares rose 108.98% to $1.56 during Friday's pre-market session. The most recent rating by H.C. Wainwright, on Mar 24, is at Buy...
